Efficacy and safety of Mavacamten: A new era in the treatment of hypertrophic cardiomyopathy

Eur J Intern Med. 2022 Dec:106:144-146. doi: 10.1016/j.ejim.2022.08.023. Epub 2022 Aug 29.

Authors

Mahnoor Sukaina¹, Marium Waheed², Naba Ali², Raffat Rasool²

Affiliations

¹ Karachi Medical and Dental College, Karachi, Pakistan. Electronic address: msukainavazir193@gmail.com.
² Karachi Medical and Dental College, Karachi, Pakistan.

PMID: 36050261
DOI: 10.1016/j.ejim.2022.08.023

No abstract available

Publication types

Letter

MeSH terms

Benzylamines
Cardiomyopathy, Hypertrophic* / drug therapy
Humans
Uracil

Substances

MYK-461
Benzylamines
Uracil